Table 2

Prevalence of stages of chronic kidney disease according to the various estimating equations
Marker Stage of Description eGFRa Men Women Total
CKD N (%) N (%) N (%)
MDRD - No kidney damage with normal or mildly decreased eGFR ≥60 532 (63.6) 368 (58.0) 900 (61.2)
1 Kidney damage with normal eGFR ≥90 3 (0.4) 1 (0.2) 4 (0.3)
2 Kidney damage with mildly decreased eGFR 60–89 46 (5.5) 17 (2.7) 63 (4.3)
3 Moderately decreased eGFR 30–59 245 (29.3) 239 (37.6) 484 (32.9)
4/5 Severely decreased eGFR, kidney failure <30 10 (1.2) 10 (1.6) 20 (1.4)
CKD-EPI - No kidney damage with normal or mildly decreased eGFR ≥60 523 (62.6) 396 (62.4) 919 (62.5)
1 Kidney damage with normal eGFR ≥90 2 (0.2) 1 (0.2) 3 (0.2)
2 Kidney damage with mildly decreased eGFR 60–89 46 (5.5) 17 (2.7) 63 (4.3)
3 Moderately decreased eGFR 30–59 253 (30.3) 209 (32.9) 462 (31.4)
4/5 Severely decreased eGFR, kidney failure <30 12 (1.4) 12 (1.9) 24 (1.6)
Cystatin-C based eGFR - No kidney damage with normal or mildly decreased eGFR ≥60 645 (77.2) 522 (82.2) 1167 (79.3)
1 Kidney damage with normal eGFR ≥90 18 (2.2) 4 (0.6) 22 (1.5)
2 Kidney damage with mildly decreased eGFR 60–89 53 (6.3) 15 (2.4) 68 (4.6)
3 Moderately decreased eGFR 30–59 113 (13.5) 89 (14.0) 202 (13.7)
4/5 Severely decreased eGFR, kidney failure <30 7 (0.8) 5 (0.8) 12 (0.8)

a = mL/min per 1.73 m2.

Rothenbacher et al.

Rothenbacher et al. BMC Public Health 2012 12:343   doi:10.1186/1471-2458-12-343

Open Data